牛牛AI助理已提取核心訊息
On February 19, 2024, Collective Audience, Inc., a Delaware-based company, announced the successful closure of a private placement offering. The company entered into a securities purchase agreement with certain investors, issuing warrants to purchase up to 1,000,000 shares of its common stock at an exercise price of $5.00 per share, generating an aggregate gross proceeds of approximately $10,000. These warrants are immediately exercisable and will expire five years from the date of issuance. The company has committed to making reasonable efforts to register the Warrant Shares on a Form S-1 registration statement under the Securities Act of 1933 within fifteen days following the closing. Notably, the offering was completed without the involvement of any underwriters or placement agents.
On February 19, 2024, Collective Audience, Inc., a Delaware-based company, announced the successful closure of a private placement offering. The company entered into a securities purchase agreement with certain investors, issuing warrants to purchase up to 1,000,000 shares of its common stock at an exercise price of $5.00 per share, generating an aggregate gross proceeds of approximately $10,000. These warrants are immediately exercisable and will expire five years from the date of issuance. The company has committed to making reasonable efforts to register the Warrant Shares on a Form S-1 registration statement under the Securities Act of 1933 within fifteen days following the closing. Notably, the offering was completed without the involvement of any underwriters or placement agents.
2024年2月19日，總部位於特拉華州的公司Collective Audience, Inc. 宣佈成功完成私募發行。該公司與某些投資者簽訂了證券購買協議，發行了認股權證，以每股5.00美元的行使價購買多達1,000,000股普通股，總收益約爲1萬美元。這些認股權證可立即行使，並將自發行之日起五年內到期。該公司承諾做出合理努力，在收盤後十五天內根據1933年《證券法》在S-1表格註冊聲明中註冊認股權證。值得注意的是，此次發行是在沒有任何承銷商或配售代理人蔘與的情況下完成的。
2024年2月19日，總部位於特拉華州的公司Collective Audience, Inc. 宣佈成功完成私募發行。該公司與某些投資者簽訂了證券購買協議，發行了認股權證，以每股5.00美元的行使價購買多達1,000,000股普通股，總收益約爲1萬美元。這些認股權證可立即行使，並將自發行之日起五年內到期。該公司承諾做出合理努力，在收盤後十五天內根據1933年《證券法》在S-1表格註冊聲明中註冊認股權證。值得注意的是，此次發行是在沒有任何承銷商或配售代理人蔘與的情況下完成的。
有用
沒用